Giunzioni, Ilaria
Oregon Health & Science University · Vanderbilt University · VA Tennessee Valley Healthcare System · Vanderbilt University Medical Center
3 papers on CoChat
Most cited papers
- Verified
Loss of Macrophage Low-Density Lipoprotein Receptor–Related Protein 1 Confers Resistance to the Antiatherogenic Effects of Tumor Necrosis Factor-α Inhibition
Zhu, L., Giunzioni, I., Tavori, H., Covarrubias, R., Ding, L., Zhang, Y., Ormseth, M., Major, A. S., Stafford, J. M., Linton, M. F., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology
Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism
Cited by 46
- Verified
PCSK9 inhibition to reduce cardiovascular disease risk: recent findings from the biology of PCSK9
Tavori, H., Giunzioni, I., & Fazio, S. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 30
- Verified
Macrophage-derived apoESendai suppresses atherosclerosis while causing lipoprotein glomerulopathy in hyperlipidemic mice
Tavori, H., Fan, D., Giunzioni, I., Zhu, L., Linton, M. F., Fogo, A. B., & Fazio, S. (2014) · Journal of Lipid Research
Atherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism
Cited by 10
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free